key visual:DesignCell

DesignCell ®

Treating cancer and other intractable diseases at reasonable cost

  1. Now
    • Cell Survivor Treatment and Regenerative Medicine Clinically Started
  2. 2030
    • The market for cell survivorship treatment and regenerative medicine is growing
  3. 2050

We develop gene modification technology and next-generation automated cell culture technology based on digital x bio fusion to rationalize the cost of advanced medical care, and build a total seamless solution for designed cell pharmaceuticals to overcome intractable diseases such as cancer and realize a society where everyone can live a vibrant life.

External announcement

R&D Topics, News Release, Academic conferences, papers, events, etc.

This article is a sponsored article by
''.